BR9803237A - Derivados de uréia. - Google Patents

Derivados de uréia.

Info

Publication number
BR9803237A
BR9803237A BR9803237-2A BR9803237A BR9803237A BR 9803237 A BR9803237 A BR 9803237A BR 9803237 A BR9803237 A BR 9803237A BR 9803237 A BR9803237 A BR 9803237A
Authority
BR
Brazil
Prior art keywords
urea derivatives
represents hydrogen
compounds
halogen
processes
Prior art date
Application number
BR9803237-2A
Other languages
English (en)
Other versions
BR9803237B1 (pt
Inventor
Daniel Jasserand
Samuel David
Jochen Antel
Reinhard Brueckner
Christian Eeckhout
Gerhard-Wilhelm Bielenberg
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR9803237A publication Critical patent/BR9803237A/pt
Publication of BR9803237B1 publication Critical patent/BR9803237B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção:<B>"DERIVADOS DE URéIA"<D>. Descrevem-se compostos de fórmula I em que R^ 1^ representa hidrogênio ou alquila inferior, R^ 2^ representa hidrogênio ou halogênio e R^ 3^ representa hidrogênio ou alcóxi inferior e respectivos sais de adição de ácido fisiologicamente aceitáveis e fármacos contendo estes compostos bem como processos para a sua preparação.
BRPI9803237-2A 1997-08-27 1998-08-26 derivados de uréia, composição farmacêutica e processo para sua preparação. BR9803237B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737274 1997-08-27

Publications (2)

Publication Number Publication Date
BR9803237A true BR9803237A (pt) 2000-02-08
BR9803237B1 BR9803237B1 (pt) 2009-05-05

Family

ID=7840297

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9803237-2A BR9803237B1 (pt) 1997-08-27 1998-08-26 derivados de uréia, composição farmacêutica e processo para sua preparação.

Country Status (24)

Country Link
US (1) US6001833A (pt)
JP (1) JP4250228B2 (pt)
KR (1) KR19990023605A (pt)
CN (1) CN1108290C (pt)
AR (1) AR015147A1 (pt)
AU (1) AU744104B2 (pt)
BR (1) BR9803237B1 (pt)
CA (1) CA2245484C (pt)
CZ (1) CZ267198A3 (pt)
DE (1) DE19824865A1 (pt)
DZ (1) DZ2597A1 (pt)
HK (1) HK1019604A1 (pt)
HU (1) HUP9801889A1 (pt)
ID (1) ID20787A (pt)
IL (1) IL125885A (pt)
NO (1) NO314939B1 (pt)
NZ (1) NZ331524A (pt)
PL (1) PL193724B1 (pt)
RU (1) RU2198883C2 (pt)
SK (1) SK111098A3 (pt)
TR (1) TR199801683A2 (pt)
TW (1) TW520368B (pt)
UA (1) UA60300C2 (pt)
ZA (1) ZA986721B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10036818A1 (de) 2000-07-28 2002-02-07 Solvay Pharm Gmbh Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
UA75425C2 (en) * 2001-07-09 2006-04-17 Piperazine oxime derivatives with antagonistic activity to nk-1 receptor, use thereof, a pharmaceutical composition based thereon, a method for producing and a method for producing intermediary compounds
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
AU706021B2 (en) * 1995-05-25 1999-06-03 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
GB9519077D0 (en) * 1995-09-18 1995-11-15 Fujisawa Pharmaceutical Co New heterocyclic compounds
FR2744449B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
JP4189043B2 (ja) * 1996-09-30 2008-12-03 株式会社資生堂 Ｎ−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤

Also Published As

Publication number Publication date
DE19824865A1 (de) 1999-03-04
CA2245484A1 (en) 1999-02-27
CN1218044A (zh) 1999-06-02
CN1108290C (zh) 2003-05-14
TW520368B (en) 2003-02-11
NZ331524A (en) 2000-02-28
JP4250228B2 (ja) 2009-04-08
AU744104B2 (en) 2002-02-14
UA60300C2 (uk) 2003-10-15
NO314939B1 (no) 2003-06-16
BR9803237B1 (pt) 2009-05-05
SK111098A3 (en) 1999-05-07
TR199801683A3 (tr) 1999-03-22
NO983918L (no) 1999-03-01
DZ2597A1 (fr) 2003-03-01
RU2198883C2 (ru) 2003-02-20
TR199801683A2 (xx) 1999-03-22
US6001833A (en) 1999-12-14
JPH11140082A (ja) 1999-05-25
HU9801889D0 (en) 1998-10-28
CZ267198A3 (cs) 1999-03-17
NO983918D0 (no) 1998-08-26
HK1019604A1 (en) 2000-02-18
IL125885A0 (en) 1999-04-11
ZA986721B (en) 1999-02-02
AU8189998A (en) 1999-03-11
AR015147A1 (es) 2001-04-18
CA2245484C (en) 2008-04-29
PL193724B1 (pl) 2007-03-30
IL125885A (en) 2000-08-13
KR19990023605A (ko) 1999-03-25
PL328221A1 (en) 1999-03-01
ID20787A (id) 1999-03-04
HUP9801889A1 (hu) 2000-11-28

Similar Documents

Publication Publication Date Title
BR0008331A (pt) Derivados de 16-halogeno-epotilon, processos para a sua preparação e seu emprego farmacêutico
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR9912188A (pt) Derivados de 1,1-dióxido de benzo (b) tiepina, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
SE0001899D0 (sv) New compounds
BR9916111A (pt) Derivados de fenilglicina
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
BR9901111A (pt) Corantes contendo derivados de diamino-benzeno bem como derivados de diamino-benzeno
BR0310077A (pt) Novos compostos e sua utilização
BR9910540A (pt) Derivados de 2-(2-metilfenil)-3,4-dihidro-2h-pirrol
BR9910539A (pt) Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
PT839041E (pt) Sais de derivados de amidina e de inibidor de ciclooxigenase processo para a sua preparacao sua utilizacao como farmacos e composicoes farmaceuticas contendo os referidos sais
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
TR200000116T2 (tr) Anestetik bir bileşiğin berrak, enjekte edilebilen formülasyonu
BR9914266A (pt) Derivados de propanolamina substituìdos por heterociclos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego
BR0103048A (pt) Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina
BR9714215A (pt) Derivados de benzoato de 1,4-diazabiciclo[2.2.2]oct-2-ilmetila, seu preparo e sua aplicação em terapêutica
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
DE69819539D1 (de) Antithrombotische mittel
BG106847A (en) Substituted piperazine derivatives as mtp inhibitors
BR9803237A (pt) Derivados de uréia.
BR9915027A (pt) Derivados de 1,3-diaril-2-piridin-2-il-3-(3-piridin-2-ilamino)-propanol susbtituìdos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego
BR9913337A (pt) Derivados tan-1057
ATE234086T1 (de) Creatine derivate für asthma

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/05/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2259 DE 22-04-2014 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.